NovaDigm Therapeutics, Inc.

Quick facts

Phase 1 pipeline

• NDV-3
• NDV-3 investigational vaccine
• NDV-3 vaccine with alum IM
• NDV-3 vaccine without alum ID
• NDV-3 vaccine without alum IM

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• NovaDigm Therapeutics, Inc. portfolio CI brief
• NovaDigm Therapeutics, Inc. pipeline updates RSS